Kris MG - Search Results

1

Phase II Study of a Non-Platinum-Containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab as Initial Therapy for Patients with Advanced Lung Adenocarcinomas.

Pietanza MC, Hellmann MD, Fiore JJ, Smith-Marrone S, Basch EM, Schwartz LH, Ginsberg MS, Shouery M, Newman SK, Shaw M, Rogak LJ, Lash AE, Hilden P, Kris MG. Pietanza MC, et al. Among authors: kris mg. J Thorac Oncol. 2016 Jun;11(6):890-9. doi: 10.1016/j.jtho.2016.02.018. Epub 2016 Mar 8. J Thorac Oncol. 2016. PMID: 26964771 Free PMC article. Clinical Trial.

2

Phase II trial of amonafide in patients with stage III and IV non-small-cell lung cancer.

Berger MZ, Kris MG, Gralla RJ, Marks LD, Potanovich LM, Dimaggio JJ, Heelan RT. Berger MZ, et al. Among authors: kris mg. Am J Clin Oncol. 1991 Apr;14(2):124-6. doi: 10.1097/00000421-199104000-00006. Am J Clin Oncol. 1991. PMID: 1851387

3

Phase II trial of trimetrexate in patients with stage III and IV non-small-cell lung cancer.

Kris MG, D'Acquisto RW, Gralla RJ, Burke MT, Marks LD, Fanucchi MP, Heelan RT. Kris MG, et al. Am J Clin Oncol. 1989 Feb;12(1):24-6. doi: 10.1097/00000421-198902000-00006. Am J Clin Oncol. 1989. PMID: 2536213

4

Phase II study of 10-ethyl-10-deaza-aminopterin in patients with stage III and IV non-small-cell lung cancer.

Shum KY, Kris MG, Gralla RJ, Burke MT, Marks LD, Heelan RT. Shum KY, et al. Among authors: kris mg. J Clin Oncol. 1988 Mar;6(3):446-50. doi: 10.1200/JCO.1988.6.3.446. J Clin Oncol. 1988. PMID: 2832548

5

Chemotherapy in non-small cell lung cancer: results of recent trials.

Gralla RJ, Kris MG. Gralla RJ, et al. Among authors: kris mg. Semin Oncol. 1988 Jun;15(3 Suppl 4):2-5. Semin Oncol. 1988. PMID: 2839904 Review.

6

Trial of vindesine plus mitomycin in stage-3 non-small cell lung cancer. An active regimen for outpatient treatment.

Kris MG, Gralla RJ, Kelsen DP, Casper ES, Burke MT, Fiore JJ, Cibas IR, Heelan RT. Kris MG, et al. Chest. 1985 Mar;87(3):368-72. doi: 10.1378/chest.87.3.368. Chest. 1985. PMID: 2982552 Clinical Trial.

7

Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy.

O'Connell JP, Kris MG, Gralla RJ, Groshen S, Trust A, Fiore JJ, Kelsen DP, Heelan RT, Golbey RB. O'Connell JP, et al. Among authors: kris mg. J Clin Oncol. 1986 Nov;4(11):1604-14. doi: 10.1200/JCO.1986.4.11.1604. J Clin Oncol. 1986. PMID: 3021920

8

Phase II trial of esorubicin in patients with advanced non-small cell lung cancer.

Kris MG, Gralla RJ, Burke MT, Fiore JJ, Kelsen DP, Marks LD, Heelan RT. Kris MG, et al. Cancer Treat Rep. 1987 Jul-Aug;71(7-8):783-4. Cancer Treat Rep. 1987. PMID: 3038319 No abstract available.

9

Phase I trial and clinical pharmacological evaluation of 10-ethyl-10-deazaaminopterin in adult patients with advanced cancer.

Kris MG, Kinahan JJ, Gralla RJ, Fanucchi MP, Wertheim MS, O'Connell JP, Marks LD, Williams L, Farag F, Young CW, et al. Kris MG, et al. Cancer Res. 1988 Oct 1;48(19):5573-9. Cancer Res. 1988. PMID: 3416310 Clinical Trial.

10

Trial of the combination of mitomycin, vindesine, and cisplatin in patients with advanced non-small cell lung cancer.

Kris MG, Gralla RJ, Wertheim MS, Kelsen DP, O'Connell JP, Burke MT, Fiore JJ, Cibas IR, Heelan RT. Kris MG, et al. Cancer Treat Rep. 1986 Sep;70(9):1091-6. Cancer Treat Rep. 1986. PMID: 3527408 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

522 results

Search Page

Filters